Resources Hub
Ashpalion 25 years logo

SPIOMET4HEALTH project | Clinical trials

PCOS affects between 5 and 10% of women of reproductive age and can cause increased body hair and acne, irregular menstrual periods, and fertility problems. It is the most common endocrine disorder in women of reproductive age but is still one of the most unknown pathologies among the general population. It can also lead to the development of other diseases such as type 2 diabetes, cancer before menopause, and anxiety or depression, which can greatly impact the quality of life for women affected by the condition.

PCOS affects between 5 and 10% of women of reproductive age and can cause increased body hair and acne, irregular menstrual periods, and fertility problems. It is the most common endocrine disorder in women of reproductive age but is still one of the most unknown pathologies among the general population. It can also lead to the development of other diseases such as type 2 diabetes, cancer before menopause, and anxiety or depression, which can greatly impact the quality of life for women affected by the condition.
April 17, 2023
|

You can now participate in the clinical trial for polycystic ovary syndrome (PCOS) in Norway, Denmark, Italy, Austria, Turkey and Spain!

The clinical trials is aimed at girls and women with Polycystic Ovary Syndrome (PCOS) and who fulfill the following criteria:

✔ 12-24 years

✔ Irregular periods

✔ High amount of body hair

Spiomet4Health aims to provide a novel treatment for adolescent girls and young adult women with Polycystic Ovary Syndrome (PCOS). At ASPHALION, we are proud regulatory partners of this EU-funded HORIZON project. We are committed to improving women’s health!

➥ Come join Spiomet4Health clinicaltrials!

ℹ Further information ⬇

 

You can now participate in the clinical trial for Polycystic Ovary Syndrome (PCOS) in Norway, Denmark, Italy, Austria, Turkey and Spain

Search News & Events

  • Search

  • Filter by category

Share

Related news and events

ETERNAL | 6th General Assembly meeting

March 11, 2025

The 6th General Assembly meeting of the ETERNAL project successfully wrapped up last week! Hosted by Universität für Bodenkultur Wien, the meeting featured valuable updates

EVENT | DIA Europe

February 25, 2025

DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2025 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role in making it happen.

HORIZON EUROPE | NABIHEAL progress meeting

February 5, 2025

Two years into the NABIHEAL project, Asphalion experts Marta Rayo Lunar and Sergio Veiga attended the consortium meeting in Zagreb, hosted by IMI, to review

More news & Events

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Logo Asphalion
Free Meeting

Services

SDGs

Sustainable Development Goals - Logo

As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.

Memberships & PartnershipS

Catalonia.health
Catalonia Trade & Investment - ACCIÓ
Team PRRC
Veeva Certified Partner
Navarra Health Cluster
Cluster MAD eHealth

Quality Management System

Innovative SME

SDGs

Sustainable Development Goals - Logo

As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.

© Asphalion

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule Now!
Schedule a meeting